Xiaorui Cao

660 total citations
17 papers, 495 citations indexed

About

Xiaorui Cao is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Xiaorui Cao has authored 17 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in Xiaorui Cao's work include Bone Metabolism and Diseases (4 papers), Orthopaedic implants and arthroplasty (3 papers) and MicroRNA in disease regulation (3 papers). Xiaorui Cao is often cited by papers focused on Bone Metabolism and Diseases (4 papers), Orthopaedic implants and arthroplasty (3 papers) and MicroRNA in disease regulation (3 papers). Xiaorui Cao collaborates with scholars based in China and Australia. Xiaorui Cao's co-authors include Dawei Zhang, Guangyue Zhao, Qingsheng Zhu, Jun Li, Zifan Lu, Jinyu Zhu, Yan Zhao, Yanwu Liu, Shu Zhu and Huan Li and has published in prestigious journals such as Scientific Reports, Endocrinology and Frontiers in Immunology.

In The Last Decade

Xiaorui Cao

16 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaorui Cao China	12	217	108	102	62	62	17	495
Zuolong Wu China	11	264 1.2×	62 0.6×	136 1.3×	53 0.9×	44 0.7×	24	574
Li Wei China	12	339 1.6×	50 0.5×	93 0.9×	50 0.8×	118 1.9×	40	794
Marieke Rienks Netherlands	11	324 1.5×	42 0.4×	99 1.0×	163 2.6×	72 1.2×	15	748
Chunyan Xia China	14	211 1.0×	67 0.6×	114 1.1×	150 2.4×	65 1.0×	33	612
Xia Pan China	14	277 1.3×	72 0.7×	162 1.6×	94 1.5×	155 2.5×	36	725
Nabil A. Rashdan United States	13	197 0.9×	36 0.3×	48 0.5×	65 1.0×	25 0.4×	18	460
Emanuela Lococo Italy	13	163 0.8×	137 1.3×	20 0.2×	41 0.7×	51 0.8×	16	509
Jera Jeruc Slovenia	13	222 1.0×	45 0.4×	103 1.0×	88 1.4×	45 0.7×	31	466
Tetyana G Voloshenyuk United States	9	249 1.1×	31 0.3×	93 0.9×	99 1.6×	61 1.0×	13	685

Countries citing papers authored by Xiaorui Cao

Since Specialization

Citations

This map shows the geographic impact of Xiaorui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorui Cao more than expected).

Fields of papers citing papers by Xiaorui Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorui Cao. The network helps show where Xiaorui Cao may publish in the future.

Co-authorship network of co-authors of Xiaorui Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorui Cao. A scholar is included among the top collaborators of Xiaorui Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorui Cao. Xiaorui Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhao, Yan, Banjun Ruan, Zheng Zhu, Xiaorui Cao, & Zifan Lu. (2025). Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway. Human Cell. 38(3). 73–73.

Cao, Xiaorui, et al.. (2024). DEMF-Net: A dual encoder multi-scale feature fusion network for polyp segmentation. Biomedical Signal Processing and Control. 96. 106487–106487. 6 indexed citations

Zhao, Yan, Banjun Ruan, Shan Wang, et al.. (2023). RNA-binding Protein QKI Inhibits Osteogenic Differentiation Via Suppressing Wnt Pathway. Archives of Medical Research. 54(5). 102853–102853. 5 indexed citations

Xu, Tingfa, et al.. (2022). Deep Learning in Medical Hyperspectral Images: A Review. Sensors. 22(24). 9790–9790. 50 indexed citations

Du, Tianshu, Yan Zhao, Shu Zhu, et al.. (2020). QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism. Cell Death and Disease. 11(5). 330–330. 24 indexed citations

Guo, Kai, Xin Bu, Chongfei Yang, et al.. (2019). Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis. Frontiers in Immunology. 9. 3133–3133. 28 indexed citations

Zhao, Yan, Shu Zhu, Hanli Wang, et al.. (2019). MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation. Pharmacological Research. 147. 104381–104381. 48 indexed citations

Zhao, Yan, Shu Zhu, Zichen Ye, et al.. (2018). Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion. Journal of Bone and Mineral Metabolism. 37(3). 399–410. 8 indexed citations

Zhao, Yan, Jinyu Zhu, Zifan Lu, et al.. (2018). Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype. Molecular Medicine. 24(1). 20–20. 37 indexed citations

10.

Zhang, Dawei, Xiaorui Cao, Jun Li, & Guangyue Zhao. (2015). MiR-210 inhibits NF-κB signaling pathway by targeting DR6 in osteoarthritis. Scientific Reports. 5(1). 12775–12775. 89 indexed citations

11.

Zhang, Dawei, et al.. (2015). Osteoprotective Effect of Cordycepin on Estrogen Deficiency-Induced OsteoporosisIn VitroandIn Vivo. BioMed Research International. 2015. 1–6. 19 indexed citations

12.

Cai, Yan, Xia Li, Yusheng Wang, et al.. (2014). Hyperglycemia promotes vasculogenesis in choroidal neovascularization in diabetic mice by stimulating VEGF and SDF-1 expression in retinal pigment epithelial cells. Experimental Eye Research. 123. 87–96. 23 indexed citations

13.

Liu, Yanwu, Lingjuan Wang, Yaoping Wu, et al.. (2013). Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. Toxicology. 304. 120–131. 49 indexed citations

14.

Cao, Xiaorui, Huan Li, Huiren Tao, et al.. (2013). Metformin Inhibits Vascular Calcification in Female Rat Aortic Smooth Muscle Cells via the AMPK-eNOS-NO Pathway. Endocrinology. 154(10). 3680–3689. 74 indexed citations

15.

Cao, Xiaorui, et al.. (2012). The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover. Journal of Surgical Research. 179(1). e107–e115. 17 indexed citations

16.

Cao, Xiaorui, et al.. (2012). Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover. BMC Musculoskeletal Disorders. 13(1). 97–97. 12 indexed citations

17.

Zhang, Dawei, Quansheng Yang, Jinyu Zhu, et al.. (2007). Amelioration of osteoarthritis by intra-articular hyaluronan synthase 2 gene therapy. Medical Hypotheses. 69(5). 1111–1113. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact